Figure 2.
Particle size distributions in SLM formulations with Compritol (a) and stearic acid (b): placebo (F1L and F6L), with cyclosporine (CsA) (F2L and F3L) and with spironolactone (SPIR) (F9L and F10L).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.